BDBM39630 3-(5-bromo-2-furanyl)-5-[(2,4-difluorophenoxy)methyl]-1,2,4-oxadiazole::3-(5-bromo-2-furyl)-5-[(2,4-difluorophenoxy)methyl]-1,2,4-oxadiazole::3-(5-bromofuran-2-yl)-5-[(2,4-difluorophenoxy)methyl]-1,2,4-oxadiazole::5-[[2,4-bis(fluoranyl)phenoxy]methyl]-3-(5-bromanylfuran-2-yl)-1,2,4-oxadiazole::MLS000119221::SMR000096144::cid_1520648

SMILES CNC(=O)c1ccc2cc1Nc1nc(ncc1C(F)(F)F)Nc1ccc(OC)c(c1)OC/C=C\CCO2

InChI Key InChIKey=XZYCMAHOMGSHMC-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 39630   

TargetSerine/threonine-protein kinase ULK1(Human)
Salk Institute

US Patent
LigandChemical structure of BindingDB Monomer ID 39630BDBM39630(US12594277, Compound 21)
Affinity DataIC50: 20nMAssay Description:Sanford-Burnham Center for Chemical Genomics (SBCCG) Sanford-Burnham Medical Research Institute (SBMRI, San Diego, CA) NIH Molecular Libraries Screen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/17/2026
Entry Details
US Patent